ODI Pharma AB (ODI.ST)

SEK 2.76

(-8.0%)

Annual Income Statements

(In SEK)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 22.44 Million 139.45 Thousand 312.93 Thousand - - -
Cost of Revenue 23.78 Million 6.57 Million 7.54 Million 6975.00 12.26 Thousand 2104.00
Gross Profit -1.34 Million -6.43 Million -7.23 Million -6975.00 -12.26 Thousand -2104.00
Operating Expenses -5.00 375 Thousand 7.1 Million 3.91 Million 4.7 Million 3.45 Million
Selling, General and Administrative Expenses -5.00 375 Thousand - 3.91 Million 4.7 Million 3.45 Million
Research and Development Expenses - - - - - -
Other Expenses - - - - - -
Cost and Expenses 23.78 Million 6.95 Million 7.54 Million 3.92 Million 4.71 Million 3.46 Million
Operating Income -1.34 Million -6.81 Million -7.23 Million -3.92 Million -4.71 Million -3.46 Million
Interest Expense 819.87 Thousand 107.66 Thousand 28.76 Thousand 14.56 Thousand 7798.00 8920.00
Income Tax Expense 188.58 Thousand 6017.00 3508.00 14.37 Thousand 20.04 Thousand 282.86 Thousand
Earnings before Tax 544.56 Thousand -6.89 Million -7.23 Million -3.96 Million -4.94 Million -3.34 Million
Net Income 355.97 Thousand -6.9 Million -7.23 Million -3.98 Million -4.96 Million -3.63 Million
Earnings Per Share Basic 0.02 -0.45 -0.48 -0.26 -0.33 -0.24
Earnings Per Share Diluted 0.02 -0.45 -0.48 -0.26 -0.33 -0.24
Weighted Average Shares Outstanding 15.22 Million 15.22 Million 15.22 Million 15.22 Million 15.22 Million 15.22 Million
Weighted Average Shares Outstanding (Diluted) 15.22 Million 15.22 Million 15.22 Million 15.22 Million 15.22 Million 15.22 Million
Gross Margin -0.06 -46.16 -23.10 - - -
EBIT Margin 0.06 -48.82 -23.09 - - -
Profit Margin 0.02 -49.49 -23.13 - - -
EBITDA 1.36 Million -6.89 Million -7.2 Million -3.96 Million -4.92 Million -3.33 Million
Earnings Before Tax Margin -0.06 -48.85 -23.10 - - -

Income Statement Charts